370 related articles for article (PubMed ID: 26921929)
1. Managing the menopause: An update.
Roberts H; Hickey M
Maturitas; 2016 Apr; 86():53-8. PubMed ID: 26921929
[TBL] [Abstract][Full Text] [Related]
2. The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
[TBL] [Abstract][Full Text] [Related]
3. Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA; Crider M; Hill SR
Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
[TBL] [Abstract][Full Text] [Related]
4. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
Zeleke BM; Bell RJ; Billah B; Davis SR
Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
Umland EM
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
[TBL] [Abstract][Full Text] [Related]
6. Approach to the patient with menopausal symptoms.
Martin KA; Manson JE
J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
[TBL] [Abstract][Full Text] [Related]
7. Management of Menopausal Symptoms: A Review.
Crandall CJ; Mehta JM; Manson JE
JAMA; 2023 Feb; 329(5):405-420. PubMed ID: 36749328
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.
Simon JA; Snabes MC
Expert Opin Investig Drugs; 2007 Dec; 16(12):2005-20. PubMed ID: 18042008
[TBL] [Abstract][Full Text] [Related]
9. Role of hormone therapy in the management of menopause.
Shifren JL; Schiff I
Obstet Gynecol; 2010 Apr; 115(4):839-855. PubMed ID: 20308847
[TBL] [Abstract][Full Text] [Related]
10. [Few alternatives to estrogen replacement therapy for vegetative symptoms after menopause].
Hammar M; Nedstrand E; Wyon Y
Lakartidningen; 2004 Apr; 101(18):1612-6. PubMed ID: 15185538
[TBL] [Abstract][Full Text] [Related]
11. Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause.
Larson B; Collins A; Landgren BM
Maturitas; 1997 Dec; 28(2):99-105. PubMed ID: 9522318
[TBL] [Abstract][Full Text] [Related]
12. Update on hormone therapy for the management of postmenopausal women.
Pan M; Pan X; Zhou J; Wang J; Qi Q; Wang L
Biosci Trends; 2022 Mar; 16(1):46-57. PubMed ID: 35013031
[TBL] [Abstract][Full Text] [Related]
13. Hormone Therapy for Relieving Postmenopausal Vasomotor Symptoms: A Systematic Review.
Abdi F; Mobedi H; Mosaffa N; Dolatian M; Ramezani Tehrani F
Arch Iran Med; 2016 Feb; 19(2):141-6. PubMed ID: 26838086
[TBL] [Abstract][Full Text] [Related]
14. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
15. The Timing Hypothesis: Hormone Therapy for Treating Symptomatic Women During Menopause and Its Relationship to Cardiovascular Disease.
Mehta JM; Chester RC; Kling JM
J Womens Health (Larchmt); 2019 May; 28(5):705-711. PubMed ID: 30484736
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy for the management of menopause symptoms.
Collins Fantasia H; Sutherland MA
J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
18. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
19. The 2017 hormone therapy position statement of The North American Menopause Society.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
Gast GC; Pop VJ; Samsioe GN; Grobbee DE; Nilsson PM; Keyzer JJ; Wijnands-van Gent CJ; van der Schouw YT
Maturitas; 2011 Dec; 70(4):373-8. PubMed ID: 21978631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
